Join
Live feed
·
PRReleasevia Quantisnow
Avalo Therapeutics Inc. logo
ACELYRIN INC. logo

Avalo Acquires Anti-IL-1β mAb and Announces Private Placement Financing of up to $185 Million

ByQuantisnow·Wall Street's wire, on your screen.
AVTX· Avalo Therapeutics Inc.SLRN· ACELYRIN INC.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AVTX (Avalo Therapeutics Inc.), SLRN (ACELYRIN INC.) and more on Quantisnow.